✦ LIBER ✦

Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms

✍ Scribed by O. Spigset; K. Granberg; S. Hägg; Å. Norström; R. Dahlqvist

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphism of CYP2D6, CYP2C19, CYP2C9

✍ Jónrit Halling; Maria S. Petersen; Per Damkier; Flemming Nielsen; Philippe Grand 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 290 KB

The pharmacokinetics of ketobemidone are

✍ Ayman Al-Shurbaji; Juliette Säwe 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 84 KB

Dose-dependent inhibition of CYP1A2, CYP

✍ U. Jeppesen; L. F. Gram; K. Vistisen; S. Loft; H. E. Poulsen; K. Brøsen 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 95 KB

The relationship between clinical pharma

✍ Junichi Azuma; Tomoko Hasunuma; Masanori Kubo; Masaya Miyatake; Toshiko Koue; Ko 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 603 KB

An optimized methodology for combined ph

✍ Wim J. Tamminga; Johan Wemer; Berend Oosterhuis; Jan P.G. Brakenhoff; Mireille G 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 89 KB

CYP2D6polymorphism, tramadol pharmacokin

✍ Ondřej Slanař; Milan Nobilis; Jaroslav Květina; Jeffrey R. Idle; František Perlí 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 73 KB